FONAR CORP

Nasdaq:FONR

Electromedical & Electrotherapeutic Apparatus·MELVILLE, NY

CEO

Damadian Timothy Raymond

Summary Financials

Revenue

$102.9M

+4.3% YoY

FY 2025

Adj. EBITDA

$9.1M

8.8% margin

FY 2024

Net Income

$10.6M

10.3% margin

FY 2025

EPS (Diluted)

$0.37

FY 2015

Stock Price

$18.50

+0.1%

2026-03-09

52W Range

$12.00 – $18.86

P/E Ratio

50.0x

Market Cap

$117.6M

Cash

$56.3M

FY 2025

Total Debt

$66,938

FY 2025

Net Cash

$56.3M

FY 2025

Enterprise Value

$61.3M

Debt / EBITDA

-6.2x

FY 2025

EV / EBITDA

6.8x

Employees

—

Revenue

$102.9M

+4.3% YoY

FY 2025

Adj. EBITDA

$9.1M

8.8% margin

FY 2024

Net Income

$10.6M

10.3% margin

FY 2025

EPS (Diluted)

$0.37

FY 2015

Stock Price

$18.50

+0.1%

2026-03-09

52W Range

$12.00 – $18.86

P/E Ratio

50.0x

Market Cap

$117.6M

Cash

$56.3M

FY 2025

Total Debt

$66,938

FY 2025

Net Cash

$56.3M

FY 2025

Enterprise Value

$61.3M

Debt / EBITDA

-6.2x

FY 2025

EV / EBITDA

6.8x

Employees

—